Due to the negativity of GATA3 expression in most of the endometrial and endocervical adenocarcinoma samples, it was not possible to investigate the relationship between the expression of this marker and the clinical and histopathological features affecting the prognosis as well as the survival status in these patients. Here, GATA3 is linked to endocervical adenocarcinoma.